Skip to content

Apotheek Schreurs

Active Private limited companyfounded 2015active for 11 yearsLuikersteenweg 82, 3500 HasseltKBO/BCE: BE 0568.596.776

Lifetime

11 annual accounts with figures on one time axis
peak of €171,732 in 2021
€162,362▼ 3.0%
lowest -€8,076 in 2019
€61,411▲ 130%
peak of €211,257 in 2025
€211,257▲ 41.0%
€301,133▼ 31.5%
peak of 1.8 FTE in 2020
0.9 FTE▼ 10.0%
Board1 name since 2014
1 director
Documentsfilings and deeds
25-06-202636 days before the deadline
2025abbreviated format
Result from €26,646 to €61,411Staff from 1 FTE to 0.9 FTEEquity from €149,847 to €211,257Debts from €439,565 to €301,133

Key points

from the 2025 annual accounts

Equity

€211,257 ▲ 41.0%

Apotheek Schreurs has made a profit without a break since 2020.

Turnover

≈ €760,000 estimated

The abbreviated format states no turnover.

Staff

1 employees on 31-12-2025
012021112025

In 2025, 1 employee joined and 1 left.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,733 companies had the same profile as Apotheek Schreurs has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,733 companies, not a prediction for Apotheek Schreurs. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 29-12-2014
  • founderdeed of 14-01-2015
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0568596776
appointed as director Gazette deed
Incorporation Founding capital of €18,600, 100 shares · Founded by · appointed as manager · published on 14-01-2015 · Gazette deed
First establishment Luikersteenweg 82, Hasselt
All 22 events

Comparable companies

same main activity, similar in size and age
Company
Apotheek Schreurs Hasselt €512,390 €162,362 41.2% 0.9
Pharmacie BIHAIN Trois-Ponts €557,802 €168,122 15.5% 0.7
PHARMACIE CHATELLE Woluwe-Saint-Lambert €637,174 €170,132 35.7% 0.8
Smith Pharma Willebroek €610,521 €184,600 24.0% 1.1
APOTHEEK AERTS Londerzeel €560,147 €173,665 48.0% 1
Apotheek Louisette Maes Puurs-Sint-Amands €410,986 €187,392 33.2% 1
PHARMACIE DEJARDIN Eghezée €395,975 €145,704 6.4% 0.8

These companies have the same main activity as Apotheek Schreurs: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €396,000 and €637,000, founded between 2011 and 2016.

Official details

Source: KBO
Status
Active since 12-01-2015Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.238.314.7883500 Hasselt, since 12-01-2015
Financial year end
31 December
Peppol
Reachable since 07-10-2025
Company details

Annual accounts 2025

€512,390▼ 13.1%
Employeeson 31-12-2025
1=
Filing
Filed on 25-06-2026, 36 days before the end of the filing period
Financials

Insights on Apotheek Schreurs

Apotheek Schreurs files the abbreviated format. That format states no turnover. The gross margin rose from €117,321 in 2015 to €162,362 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Apotheek Schreurs

What is the company number of Apotheek Schreurs?
The company number of Apotheek Schreurs is 0568.596.776. The VAT number is the same number with BE in front: BE 0568.596.776.
Where is Apotheek Schreurs based?
The registered office is at Luikersteenweg 82, 3500 Hasselt.Company details
What does Apotheek Schreurs do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Schreurs?
Apotheek Schreurs is a private limited company (BV).
When was Apotheek Schreurs founded?
Apotheek Schreurs was founded on 12-01-2015.
Is Apotheek Schreurs still active?
Yes, Apotheek Schreurs is an active enterprise in the KBO register.
How many employees does Apotheek Schreurs have?
Apotheek Schreurs had an average of 0.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek Schreurs?
The turnover in financial year 2025 is about €760,000. This figure is estimated from the gross margin of €162,362 and 43 comparable companies (NACE 477). It probably lies between €500,000 and €1.6m.
Is Apotheek Schreurs profitable?
In financial year 2025, Apotheek Schreurs made a profit of €61,411.
Where can I find the annual accounts of Apotheek Schreurs?
Apotheek Schreurs filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek Schreurs due?
Apotheek Schreurs must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.